News

Published on 23 Mar 2023 on Simply Wall St. via Yahoo Finance

Estimating The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)


Article preview image

Key Insights

Using the 2 Stage Free Cash Flow to Equity, Veracyte fair value estimate is US$20.37Current share price of US$21.83 suggests Veracyte is potentially trading close to its fair value Analyst price target for VCYT is US$31.67, which is 55% above our fair value estimate

How far off is Veracyte, Inc. (NASDAQ:VCYT) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. There's really not all that much to it, even though it might appear quite complex.

NASDAQ.VCYT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
What Makes Veracyte (VCYT) a Lucrative Investment?

Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Str...

Insider Monkey via Yahoo Finance 2 Apr 2024

Veracyte's (VCYT) Q4 Loss Widens, Gross Margin Expands

Veracyte VCYT delivered a diluted loss of 39 cents per share in the fourth quarter of 2023 compar...

Zacks via Yahoo Finance 23 Feb 2024

Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript

Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript February 22, 2024 Veracyte, Inc. mi...

Insider Monkey via Yahoo Finance 23 Feb 2024

Swelling losses haven't held back gains for Veracyte (NASDAQ:VCYT) shareholders since they're up...

Veracyte, Inc. (NASDAQ:VCYT) shareholders have seen the share price descend 17% over the month. B...

Simply Wall St. via Yahoo Finance 7 Oct 2023

Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates

Veracyte (VCYT) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Esti...

Zacks via Yahoo Finance 8 Aug 2023

Veracyte, Inc.'s (NASDAQ:VCYT) Revenues Are Not Doing Enough For Some Investors

With a price-to-sales (or "P/S") ratio of 6x Veracyte, Inc. (NASDAQ:VCYT) may be sending very bul...

Simply Wall St. via Yahoo Finance 30 May 2023

Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates

Veracyte (VCYT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Esti...

Zacks via Yahoo Finance 4 May 2023

The five-year returns have been strong for Veracyte (NASDAQ:VCYT) shareholders despite underlying...

It hasn't been the best quarter for Veracyte, Inc. (NASDAQ:VCYT) shareholders, since the share pr...

Simply Wall St. via Yahoo Finance 18 Apr 2023

Estimating The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Veracyte fair value estimate is US$20.37...

Simply Wall St. via Yahoo Finance 23 Mar 2023

Best Momentum Stocks to Buy for January 24th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider...

Zacks via Yahoo Finance 24 Jan 2023